GeoWealth Management’s ResMed RMD Stock Holding History

GeoWealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-776	Closed	-$212K	–	820
2025 Q3	$212K	Buy	776 +80	+11%	+$21.9K	0.01%	678
2025 Q2	$180K	Buy	696 +236	+51%	+$56.3K	0.01%	694
2025 Q1	$103K	Sell	460 -445	-49%	-$104K	﹤0.01%	781
2024 Q4	$207K	Sell	905 -112	-11%	-$27K	0.01%	754
2024 Q3	$248K	Sell	1,017 -70	-6%	-$15.6K	0.01%	653
2024 Q2	$208K	Buy	+1,087	New	+$221K	0.01%	670

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

GeoWealth Management's RMD Position: Q4 2025 in Review

GeoWealth Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 776 shares — an estimated $212K sold.

GeoWealth Management first reported a position in RMD in Q2 2024 and held it in 6 quarters. The position peaked at $248K in Q3 2024. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

GeoWealth Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
GeoWealth Management sold 776 ResMed shares in Q4 2025, an estimated $212K.
GeoWealth Management first reported a position in ResMed in Q2 2024 and held it in 6 quarters.
GeoWealth Management's ResMed position peaked at $248K in Q3 2024.
948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on GeoWealth Management's 13F filing for Q4 2025, filed 17 Feb 2026.